Leung et al. developed a reversible inhibitor of LOX bearing an aminomethylenethiophene (AMT) scaffold, CCT365623, and proved that CCT365623 can significantly inhibit the growth and metastasis of LOX-dependent mammary tumors in the mouse model [115]. The gene discussed is LOX; the disease is breast cancer.